BioNTech (NASDAQ:BNTX) Now Covered by Analysts at Citigroup
Citigroup started coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a report issued on Thursday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $145.00 target price on the stock. Other equities analysts have also issued reports about the stock. JPMorgan Chase & Co. cut their price target on shares […]
Citigroup started coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a report issued on Thursday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $145.00 target price on the stock. Other equities analysts have also issued reports about the stock. JPMorgan Chase & Co. cut their price target on shares […]
